RCUS logo

Arcus Biosciences, Inc. (RCUS) Cash From Financing

Annual CFF:

$277.00M+$244.00M(+739.39%)
December 31, 2024

Summary

  • As of today, RCUS annual cash from financing is $277.00 million, with the most recent change of +$244.00 million (+739.39%) on December 31, 2024.
  • During the last 3 years, RCUS annual cash from financing has risen by +$40.00 million (+16.88%).
  • RCUS annual cash from financing is now -36.90% below its all-time high of $439.00 million, reached on December 31, 2020.

Performance

RCUS Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUScash flow metrics

Quarterly CFF:

$8.00M-$44.00M(-84.62%)
September 30, 2025

Summary

  • As of today, RCUS quarterly cash from financing is $8.00 million, with the most recent change of -$44.00 million (-84.62%) on September 30, 2025.
  • Over the past year, RCUS quarterly cash from financing has dropped by -$40.00 million (-83.33%).
  • RCUS quarterly cash from financing is now -97.57% below its all-time high of $328.87 million, reached on June 30, 2020.

Performance

RCUS Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUScash flow metrics

TTM CFF:

$200.00M-$40.00M(-16.67%)
September 30, 2025

Summary

  • As of today, RCUS TTM cash from financing is $200.00 million, with the most recent change of -$40.00 million (-16.67%) on September 30, 2025.
  • Over the past year, RCUS TTM cash from financing has dropped by -$82.00 million (-29.08%).
  • RCUS TTM cash from financing is now -69.71% below its all-time high of $660.18 million, reached on March 31, 2021.

Performance

RCUS TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUScash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

RCUS Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+739.4%-83.3%-29.1%
3Y3 Years+16.9%+216.1%+497.4%
5Y5 Years+10000.0%-92.6%-54.3%

RCUS Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+739.4%-96.5%+500.0%-29.1%+948.7%
5Y5-Year-36.9%>+9999.0%-96.5%+500.0%-69.7%+948.7%
All-TimeAll-Time-36.9%>+9999.0%-97.6%+500.0%-69.7%>+9999.0%

RCUS Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$8.00M(-84.6%)
$200.00M(-16.7%)
Jun 2025
-
$52.00M(-63.4%)
$240.00M(+26.3%)
Mar 2025
-
$142.00M(+7200.0%)
$190.00M(-31.4%)
Dec 2024
$277.00M(+739.4%)
-$2.00M(-104.2%)
$277.00M(-1.8%)
Sep 2024
-
$48.00M(+2300.0%)
$282.00M(+17.5%)
Jun 2024
-
$2.00M(-99.1%)
$240.00M(-8.0%)
Mar 2024
-
$229.00M(+7533.3%)
$261.00M(+690.9%)
Dec 2023
$33.00M(0.0%)
$3.00M(-50.0%)
$33.00M(-19.9%)
Sep 2023
-
$6.00M(-73.9%)
$41.20M(+9.2%)
Jun 2023
-
$23.00M(+2200.0%)
$37.73M(+97.8%)
Mar 2023
-
$1.00M(-91.1%)
$19.07M(-42.2%)
Dec 2022
$33.00M(-86.1%)
$11.20M(+342.3%)
$33.00M(-1.4%)
Sep 2022
-
$2.53M(-41.8%)
$33.48M(+3.8%)
Jun 2022
-
$4.35M(-70.9%)
$32.26M(+7.0%)
Mar 2022
-
$14.93M(+27.9%)
$30.15M(-87.3%)
Dec 2021
$237.00M
$11.67M(+785.5%)
$237.34M(+4.4%)
Sep 2021
-
$1.32M(-40.9%)
$227.35M(-31.8%)
Jun 2021
-
$2.23M(-99.0%)
$333.55M(-49.5%)
DateAnnualQuarterlyTTM
Mar 2021
-
$222.12M(>+9900.0%)
$660.18M(+50.5%)
Dec 2020
$439.00M(>+9900.0%)
$1.68M(-98.4%)
$438.68M(+0.3%)
Sep 2020
-
$107.52M(-67.3%)
$437.52M(+32.6%)
Jun 2020
-
$328.87M(>+9900.0%)
$329.96M(>+9900.0%)
Mar 2020
-
$610.00K(+17.3%)
$1.74M(+54.8%)
Dec 2019
$1.12M(-99.1%)
$520.00K(+1368.3%)
$1.12M(-18.3%)
Sep 2019
-
-$41.00K(-106.3%)
$1.37M(-2.4%)
Jun 2019
-
$649.00K(>+9900.0%)
$1.41M(+492.2%)
Mar 2019
-
-$5000.00(-100.6%)
-$359.00K(-100.3%)
Dec 2018
$129.07M(+20.2%)
$771.00K(>+9900.0%)
$129.07M(-45.2%)
Sep 2018
-
-$7000.00(+99.4%)
$235.70M(-0.1%)
Jun 2018
-
-$1.12M(-100.9%)
$235.90M(-0.7%)
Mar 2018
-
$129.43M(+20.5%)
$237.59M(+119.6%)
Dec 2017
$107.40M(+53.2%)
$107.40M(>+9900.0%)
$108.19M(>+9900.0%)
Sep 2017
-
$189.00K(-67.4%)
$797.00K(+31.1%)
Jun 2017
-
$579.00K(+1896.6%)
$608.00K(+1996.6%)
Mar 2017
-
$29.00K
$29.00K
Dec 2016
$70.10M
-
-

FAQ

  • What is Arcus Biosciences, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Arcus Biosciences, Inc.?
  • What is Arcus Biosciences, Inc. annual cash from financing year-on-year change?
  • What is Arcus Biosciences, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Arcus Biosciences, Inc.?
  • What is Arcus Biosciences, Inc. quarterly cash from financing year-on-year change?
  • What is Arcus Biosciences, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Arcus Biosciences, Inc.?
  • What is Arcus Biosciences, Inc. TTM cash from financing year-on-year change?

What is Arcus Biosciences, Inc. annual cash from financing?

The current annual cash from financing of RCUS is $277.00M

What is the all-time high annual cash from financing for Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. all-time high annual cash from financing is $439.00M

What is Arcus Biosciences, Inc. annual cash from financing year-on-year change?

Over the past year, RCUS annual cash from financing has changed by +$244.00M (+739.39%)

What is Arcus Biosciences, Inc. quarterly cash from financing?

The current quarterly cash from financing of RCUS is $8.00M

What is the all-time high quarterly cash from financing for Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. all-time high quarterly cash from financing is $328.87M

What is Arcus Biosciences, Inc. quarterly cash from financing year-on-year change?

Over the past year, RCUS quarterly cash from financing has changed by -$40.00M (-83.33%)

What is Arcus Biosciences, Inc. TTM cash from financing?

The current TTM cash from financing of RCUS is $200.00M

What is the all-time high TTM cash from financing for Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. all-time high TTM cash from financing is $660.18M

What is Arcus Biosciences, Inc. TTM cash from financing year-on-year change?

Over the past year, RCUS TTM cash from financing has changed by -$82.00M (-29.08%)
On this page